Literature DB >> 27144504

The therapeutic potential of natural killer cells to target medulloblastoma.

Antonio Pérez-Martínez1, Lucia Fernández2, Miguel Angel Díaz3.   

Abstract

Entities:  

Keywords:  MHC class I; Natural killer cell; activating NK cell receptor; inhibitory cell receptor; medulloblastoma; stimulated NK cells

Mesh：

Year:  2016        PMID： 27144504     DOI： 10.1080/14737140.2016.1184978

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN： 1473-7140            Impact factor:   4.512


× No keyword cloud information.
  7 in total

1.  Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI.

Authors:  Bridget A Kennis; Keith A Michel; William B Brugmann; Alvaro Laureano; Rong-Hua Tao; Srinivas S Somanchi; Samuel A Einstein; Javiera B Bravo-Alegria; Shinji Maegawa; Andrew Wahba; Simin Kiany; Nancy Gordon; Lucia Silla; Dawid Schellingerhout; Soumen Khatua; Wafik Zaky; David Sandberg; Laurence Cooper; Dean A Lee; James A Bankson; Vidya Gopalakrishnan
Journal:  J Neurooncol       Date:  2019-02-20       Impact factor: 4.130

2.  Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma.

Authors:  Soumen Khatua; Laurence J N Cooper; David I Sandberg; Leena Ketonen; Jason M Johnson; Michael E Rytting; Diane D Liu; Heather Meador; Prashant Trikha; Robin J Nakkula; Gregory K Behbehani; Dristhi Ragoonanan; Sumit Gupta; Aikaterini Kotrotsou; Tagwa Idris; Elizabeth J Shpall; Katy Rezvani; Rivka Colen; Wafik Zaky; Dean A Lee; Vidya Gopalakrishnan
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

3.  Subgroup-specific immune and stromal microenvironment in medulloblastoma.

Authors:  Michael Bockmayr; Malte Mohme; Frederick Klauschen; Beate Winkler; Jan Budczies; Stefan Rutkowski; Ulrich Schüller
Journal:  Oncoimmunology       Date:  2018-05-24       Impact factor: 8.110

Review 4.  The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma.

Authors:  David R Ghasemi; Gudrun Fleischhack; Till Milde; Kristian W Pajtler
Journal:  Cancers (Basel)       Date:  2022-01-28       Impact factor: 6.639

Review 5.  Immune cell landscape and immunotherapy of medulloblastoma.

Authors:  Jin Zhang; Tianyou Wang
Journal:  Pediatr Investig       Date:  2021-06-21

6.  Prognostic relevance of tumor-infiltrating lymphocytes and immune checkpoints in pediatric medulloblastoma.

Authors:  Jeroen F Vermeulen; Wim Van Hecke; Elisabeth J M Adriaansen; Mieke K Jansen; Rianne G Bouma; José Villacorta Hidalgo; Paul Fisch; Roel Broekhuizen; Wim G M Spliet; Marcel Kool; Niels Bovenschen
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

7.  Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization.

Authors:  Allison B Powell; Sridevi Yadavilli; Devin Saunders; Stacey Van Pelt; Elizabeth Chorvinsky; Rachel A Burga; Shuroug Albihani; Patrick J Hanley; Zhenhua Xu; Yanxin Pei; Eric S Yvon; Eugene I Hwang; Catherine M Bollard; Javad Nazarian; Conrad Russell Y Cruz
Journal:  J Transl Med       Date:  2019-09-23       Impact factor: 5.531
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.